Metraipolis › archive › dc_8601f5751230

Single-cell sequencing-guided design of synergistic chemo-immunotherapy nanodrugs for cGAS-STING activation in prostate cancer therapy — Europe PMC PMID:41622236

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41622236
DOI
10.1186/s12951-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-06T08:18:24.801Z
SHA-256 of the archived text
272dbc3b9d755a3f2cdbd9cd2f5903fc2b723a1856098d413cb4bbf6688ae0d7
Stable URL of this page
https://metraipolis.com/documento/dc_8601f5751230

How to cite

Single-cell sequencing-guided design of synergistic chemo-immunotherapy nanodrugs for cGAS-STING activation in prostate cancer therapy — Europe PMC PMID:41622236 — Europe PMC (en), https://europepmc.org/article/MED/41622236 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8601f5751230 (Metraipolis archive dc_8601f5751230, sha256 272dbc3b9d755a3f2cdbd9cd2f5903fc2b723a1856098d413cb4bbf6688ae0d7)
BibTeX
@misc{dc8601f5751230,
  title = {Single-cell sequencing-guided design of synergistic chemo-immunotherapy nanodrugs for cGAS-STING activation in prostate cancer therapy — Europe PMC PMID:41622236},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41622236},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8601f5751230; sha256 272dbc3b9d755a3f2cdbd9cd2f5903fc2b723a1856098d413cb4bbf6688ae0d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41622236. Agents can read the archived copy with the MCP tool read_document.